2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Fatty Liver, Nonalcoholic studies

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Fatty Liver, Nonalcoholic

2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source

Research Excerpts

Excerpt	Relevance	Reference
"Non-alcoholic fatty liver disease (NAFLD) is a common disease associated with metabolic syndrome and can lead to life-threatening complications like hepatic carcinoma and cirrhosis."	5.48	Exenatide ameliorates hepatic steatosis and attenuates fat mass and FTO gene expression through PI3K signaling pathway in nonalcoholic fatty liver disease. ( Han, C; Li, J; Li, S; Liu, X; Ma, Y; Wang, X; Zhang, J; Zhang, L; Zheng, L, 2018)
"Non-alcoholic fatty liver disease (NAFLD) is a common disease associated with metabolic syndrome and can lead to life-threatening complications like hepatic carcinoma and cirrhosis."	1.48	Exenatide ameliorates hepatic steatosis and attenuates fat mass and FTO gene expression through PI3K signaling pathway in nonalcoholic fatty liver disease. ( Han, C; Li, J; Li, S; Liu, X; Ma, Y; Wang, X; Zhang, J; Zhang, L; Zheng, L, 2018)

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Timeframe

Studies, this research(%)

All Research%

pre-1990

0 (0.00)

18.7374

1990's

0 (0.00)

18.2507

2000's

0 (0.00)

29.6817

2010's

2 (100.00)

24.3611

2020's

0 (0.00)

2.80

Authors

Authors	Studies
Pang, L	1
Liu, K	1
Liu, D	1
Lv, F	1
Zang, Y	1
Xie, F	1
Yin, J	1
Shi, Y	1
Wang, Y	1
Chen, D	1
Li, S	1
Wang, X	1
Zhang, J	1
Li, J	1
Liu, X	1
Ma, Y	1
Han, C	1
Zhang, L	1
Zheng, L	1

Studies

Pang, L

Liu, K

Liu, D

Lv, F

Zang, Y

Xie, F

Yin, J

Shi, Y

Wang, Y

Chen, D

Li, S

Wang, X

Zhang, J

Li, J

Liu, X

Ma, Y

Han, C

Zhang, L

Zheng, L

Other Studies

2 other studies available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Fatty Liver, Nonalcoholic

Article	Year
Differential effects of reticulophagy and mitophagy on nonalcoholic fatty liver disease. Cell death & disease, 2018, 01-24, Volume: 9, Issue:2 Topics: Apoptosis; Autophagy; bcl-2-Associated X Protein; Chromones; Cytoprotection; Down-Regulation; Endopl	2018
Exenatide ameliorates hepatic steatosis and attenuates fat mass and FTO gene expression through PI3K signaling pathway in nonalcoholic fatty liver disease. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2018, Volume: 51, Issue:8 Topics: Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Animals; Blood Glucose; Body Weight; Chromones; Diet,	2018

Article

Year

Differential effects of reticulophagy and mitophagy on nonalcoholic fatty liver disease.

Cell death & disease, 2018, 01-24, Volume: 9, Issue:2

Topics: Apoptosis; Autophagy; bcl-2-Associated X Protein; Chromones; Cytoprotection; Down-Regulation; Endopl

2018

Exenatide ameliorates hepatic steatosis and attenuates fat mass and FTO gene expression through PI3K signaling pathway in nonalcoholic fatty liver disease.

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2018, Volume: 51, Issue:8

Topics: Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Animals; Blood Glucose; Body Weight; Chromones; Diet,

2018